CAPSAYIL Trademark

Trademark Overview

On Saturday, January 26, 2019, a trademark application was filed for CAPSAYIL with the United States Patent and Trademark Office. The USPTO has given the CAPSAYIL trademark a serial number of 79256372. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by Boehringer Ingelheim International GmbH. The CAPSAYIL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of immunology, oncology and immuno-oncology; providing medical and scientific research information in the field of immunology, oncology and immuno-oncology
capsayil

General Information

Serial Number79256372
Word MarkCAPSAYIL
Filing DateSaturday, January 26, 2019
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5870665
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Goods and ServicesMedical and scientific research in the field of immunology, oncology and immuno-oncology; providing medical and scientific research information in the field of immunology, oncology and immuno-oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 15, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, April 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 15, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NON-FINAL ACTION WRITTEN
Thursday, April 18, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 19, 2019APPLICATION FILING RECEIPT MAILED
Saturday, May 11, 2019REFUSAL PROCESSED BY MPU
Saturday, May 11, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 24, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 17, 2019ASSIGNED TO EXAMINER
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 1, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, January 29, 2020FINAL DISPOSITION PROCESSED
Saturday, June 1, 2019REFUSAL PROCESSED BY IB
Wednesday, June 12, 2019ASSIGNED TO LIE
Wednesday, January 29, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

capsayil oncology immuno medical immunology field scientific research information providing